FMC Corp., US3024913036

FMC Corp stock falls after guidance cut as Q2 2026 results show revenue drop

Published on 09/10/2026 at 17:17 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

FMC Corp stock trades near USD 12.80 as of September 10, 2026, after the company cut its full-year 2026 guidance following weak Q2 2026 results. Q2 2026 revenue fell 17 percent year over year to USD 867 million and adjusted EPS dropped 62 percent to USD 0.26.

Agrarflugzeug sprĂĽht Pflanzenschutzmittel ĂĽber grĂĽne Maisfelder im goldenen Abendlicht
FMC Corp. Pflanzenschutz-Flugzeug sprĂĽht Insektizid ĂĽber grĂĽne Maisfelder bei goldenem Licht ISIN US3024913036, Illustration mit AI erstellt.

FMC Corp stock (ISIN US3024913036) is trading around USD 12.80 on the New York Stock Exchange as of September 10, 2026, leaving the agricultural sciences group under pressure after a sharp guidance cut tied to weaker second quarter 2026 results.

Q2 2026 results and guidance cut

According to FMC Corporation on July 29, 2026, second quarter 2026 revenue came in at USD 867 million, down 17 percent versus second quarter 2025 as the company faced weaker demand and portfolio changes.

The same Q2 2026 release from FMC Corporation highlights that revenue excluding India was USD 841 million, down 20 percent versus second quarter 2025, underscoring the impact of the company’s decision to remove India from its consolidated figures.

On a GAAP basis, FMC reported a net loss of USD 187 million in Q2 2026, a deterioration of USD 253 million compared with second quarter 2025, reflecting lower volumes, pricing pressure and restructuring charges, as detailed by FMC Corporation.

Second quarter 2026 adjusted earnings per diluted share were USD 0.26, down 62 percent versus the year-ago quarter, showing how earnings power has compressed despite cost measures, according to FMC Corporation.

The July 29, 2026 communication from FMC Corporation also reveals that full-year 2026 revenue guidance has been lowered to a range of USD 3.50 billion to USD 3.70 billion, which represents a 7 percent decline at the midpoint versus prior year revenue when adjusted for India.

Within the same updated outlook, FMC Corporation guides for 2026 adjusted EBITDA between USD 620 million and USD 680 million, implying a 23 percent decline at the midpoint versus the prior year, and expects adjusted EPS in a range of USD 1.19 to USD 1.49, a 55 percent drop at the midpoint compared with the previous year.

First quarter 2026 performance as context

Earlier in the year, FMC’s first quarter 2026 figures already pointed to a more challenging environment, even though they came in above guidance in some metrics. As reported by FMC Corporation on April 29, 2026, first quarter 2026 revenue was USD 759 million, down 4 percent versus first quarter 2025.

In that same first quarter release, FMC Corporation states that Q1 2026 revenue excluding India reached USD 762 million, also down 4 percent versus the prior-year quarter, indicating that weaker volumes and regional shifts were already visible before the more pronounced decline seen in Q2.

For Q1 2026, FMC reported a GAAP loss of USD 2.25 per diluted share, a decline of USD 2.13 compared with first quarter 2025, as noted by FMC Corporation, highlighting how restructuring and market headwinds weighed on profitability early in the year.

First quarter 2026 adjusted loss per diluted share was USD 0.23, which was USD 0.41 lower than in first quarter 2025, according to FMC Corporation, showing that the earnings decline was already underway before the subsequent guidance cut.

The Q1 2026 earnings overview on MarketBeat indicates that adjusted EPS of negative USD 0.23 in Q1 2026 beat the consensus estimate of negative USD 0.39 by USD 0.16, while reported revenue of approximately USD 762.40 million was about USD 16.98 million above expectations, suggesting that despite the year-on-year decline, execution was slightly better than analysts had anticipated.

In that same MarketBeat entry, MarketBeat notes that first quarter 2026 EBITDA of USD 72 million was USD 17 million higher than the high end of the company’s guidance range, with foreign exchange, cost and volume dynamics all proving more favorable than expected, a sign that management still has levers to mitigate some of the pressure.

Analyst reaction and stock performance

In the weeks following the Q2 2026 report, FMC shares have underperformed broad U.S. equity indices. As of September 10, 2026, a comparative overview from Pluang shows FMC Corp trading at USD 12.81, down 1.23 percent on the day in that snapshot, with the platform describing a mixed technical outlook combining bullish moving averages with overbought relative strength index signals.

The same comparison on Pluang lists FMC Corp’s market capitalization at USD 1.54 billion at the quoted price of USD 12.16 in an earlier data point, underscoring how far the company’s equity value has compressed compared with historic levels as investors price in weaker growth and profitability.

A performance review from Zacks on September 10, 2026 states that FMC shares have fallen about 9.9 percent since the last earnings report, underperforming the S&P 500 over the same period, which reflects investor unease about the guidance cut and the pace of recovery in the crop protection market.

For investors, the combination of a 17 percent year-on-year revenue decline in Q2 2026, a 62 percent drop in adjusted EPS for the same quarter and a 55 percent expected fall in full-year adjusted EPS versus 2025 makes FMC one of the more cyclical and earnings-sensitive names in the agricultural chemicals segment, based on the company’s own July 29, 2026 guidance update.

Risk factors and upcoming earnings date

In its Q2 2026 release, FMC Corporation notes that lower pricing and foreign exchange headwinds are expected to weigh on adjusted EBITDA in 2026, even as favorable cost actions partially offset these factors, underlining that margins could remain under pressure if the global agricultural cycle stays subdued.

At the same time, FMC’s free cash flow guidance for 2026 now stands between USD 75 million and USD 225 million, including a USD 200 million upfront payment related to rimisoxafen licensing, as specified in the July 29, 2026 update from FMC Corporation, a reminder that part of the expected cash generation stems from one-off items rather than recurring operations.

The earnings calendar compiled by MarketBeat currently shows FMC’s next earnings event estimated around November 4, 2026 for third quarter 2026 results, based on past reporting schedules, giving investors a reference point for when management may provide further clarity on the trajectory of volumes, pricing and margin recovery.

Stock level and investor takeaway

FMC Corp stock at around USD 12.81 on September 10, 2026 on the New York Stock Exchange represents a market capitalization of roughly USD 1.54 billion, placing the shares well below historic highs as the market digests the 17 percent Q2 2026 revenue decline and the 55 percent expected full-year adjusted EPS drop versus 2025.

FMC Corp stock key data

  • Company: FMC Corporation
  • ISIN: US3024913036
  • Ticker: FMC
  • Trading venue: New York Stock Exchange
  • Price (as of September 10, 2026): 12.81 USD
  • Market capitalization: 1.54 billion USD (as of September 10, 2026)
  • Sector / Industry: Materials / Agricultural chemicals
  • Index membership: S&P 500
  • Next earnings date: November 4, 2026 (estimated)

More news and analyses on FMC Corp stock

Disclaimer...

en | US3024913036 | FMC CORP. | boerse | 70082395 | bgmi